Getinge’s Vasoview Hemopro 3 receives FDA 510(k) clearance
The Vasoview Hemopro 3 is designed to improve procedural efficiency and patient outcomes.
11 March 2024
11 March 2024
The Vasoview Hemopro 3 is designed to improve procedural efficiency and patient outcomes.
Wellysis’ partnership with ARTELLA will facilitate the provision of an end-to-end cardiac monitoring service, initially launching in Texas.
A new report details the fears of healthcare providers over the numbers of patients postponing or canceling proceedures due to inflation.
The pilot study will examine the company’s N-tidal device with 75 children under five years old with asthma and viral wheezing.
The BAGUERA C device aims to preserve or restore motion and disc height in the cervical region after discectomy.
The CellFX nsPFA system is designed for the ablation of soft tissue during percutaneous and intraoperative surgical procedures.
Women who received Womed Leaf were 2.4 times less likely to develop adhesions compared to the control group after six weeks.
The automated closed-loop system delivered improved glycaemic and patient-reported outcomes versus traditional tech.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.